Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
711.00    2.00 (0.28%)
Bid:
710.00
Ask:
713.00
Spread: 3.00 (0.423%)
Market Cap: £690.53m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Interim Management Statement

23 Jan 2009 07:00

RNS Number : 1292M
Acal PLC
23 January 2009
 



FOR RELEASE

7.00 AM

23 JANUARY 2009

ACAL plc 

SECOND INTERIM MANAGEMENT STATEMENT

PERIOD COMMENCING 1 OCTOBER 2008

Acal plc is today issuing its second Interim Management Statement for the year ending 31 March 2009, which covers the period commencing 1 October 2008 to date and includes trading for the nine months ended 31 December 2008.

Current trading

As we have reported in earlier statements, our markets have become increasingly difficult over the last six months.

Although the Group's sales for the quarter ended 31 December 2008 were slightly ahead of the corresponding quarter to December 2007, margins within the Electronics Division were adversely impacted by the decline in sterling over the quarter.  Within the Supply Chain Division (formerly Parts Services), the new management team has commenced the integration of Service Source Europe and is working to resolve ongoing contract operating losses.

In light of current trading levels, one-off foreign exchange losses and the cost of implementing further efficiencies, the Group result for the year ending 31 March 2009 will be below market expectations.

Following the net benefit from the sale of MessageLabs Group and the acquisition of Service Source Europe Limited, the group retains significant net cash despite increasing pressures on working capital. 

With the appointment of Nick Jefferies as Group Chief Executive on 5 January 2009, we will be carrying out a comprehensive review of Acal's business and strategy. The Board remains confident in the opportunities for the development of the business.

The following material events or transactionseach of which has been previously reported, impacted the Group during the period covered by this Interim Management Statement.

MessageLabs Group Limited

The sale of MessageLabs Group Limited to Symantec was completed on 14 November 2008. The total consideration receivable by Acal for its 3.95% investment is £16.2 million of which £15.1 million was received on that date. The balance is retained in escrow and will be returned to Acal if there are no warranty claims within a 12 month period.

Service Source Europe Limited

The acquisition of 75% of Service Source Europe Limited (SSE) was completed on January 9 2009 for a consideration in cash of £1.85 million. In addition, Acal subscribed for deferred shares in SSE with a total nominal value of £346,625 in cash to enable SSE's preference shares to be redeemed.

  

For further information:-

Nicholas Jefferies ~ Chief Executive

Malcolm Cooper ~ Finance Director

Brian Coleman-Smith/James Verstringhe

Cubitt Consulting 

01483 544500

01483 544500

020 7367 5100

Notes to the Interim Management Statement

(a) This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Acal plc, as a body, in order to meet the requirements of the UK Listing Authority’s Disclosure and Transparency Rules.
 
(b) The Interim Management Statement may contain forward-looking statements which:

 

§ have been made by the directors in good faith based on the information available to them up to the time of their approval of this statement; and
 
§ should be treated with caution due to inherent uncertainties, which are beyond Acal’s ability to control or estimate precisely and include both economic and business risk factors, underlying such forward looking information.

Notes to Editors:

Acal is a leading European value-added distributor providing specialist design-in, sales and marketing services for international suppliers in the fields of Electronic Components, Supply Chain Services and Medical and Scientific products. Organised into three divisions, Acal has 15 principal trading companies of which 8 are in Continental Europe and 7 in the UK.

Acal is now Europe's strongest multi-disciplined design-in electronics distributor and has always differentiated its offering with a strong focus on demand creation and a highly skilled technical sales force. Vertec Scientific, which operates in both the UK and South Africa, represents leading manufacturers in the field of bone densitometry, medical imaging and diagnostics. The Supply Chain division provides spare parts to field services organisations and is a supplier to virtually every leading company in that market. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBCGDBXGDGGCD
Date   Source Headline
5th Nov 20077:01 amRNSNotice of Results
19th Oct 200711:16 amRNSResult of EGM
28th Sep 20075:19 pmRNSDoc re. disposal posted
27th Sep 20077:04 amRNSDISPOSAL OF IT SOLUTIONS
11th Sep 20071:33 pmRNSHolding(s) in Company
6th Aug 20074:28 pmRNSHolding(s) in Company
19th Jul 20073:43 pmRNSResult of AGM
19th Jul 20077:00 amRNSInterim Management Statement
5th Jul 200710:15 amRNSBlocklisting Interim Review
25th Jun 20075:18 pmRNSAnnual Information Update
21st Jun 20073:03 pmRNSDoc re. Report and Accounts
7th Jun 20073:39 pmRNSDirector/PDMR Shareholding
7th Jun 20073:34 pmRNSDirector/PDMR Shareholding
7th Jun 20073:32 pmRNSDirector/PDMR Shareholding
7th Jun 20073:31 pmRNSDirector/PDMR Shareholding
7th Jun 20073:22 pmRNSDirector/PDMR Shareholding
4th Jun 20077:01 amRNSFinal Results
14th May 20077:01 amRNSNotice of Results
3rd Apr 20075:21 pmRNSSecond Price Monitoring Extn
3rd Apr 20075:20 pmRNSPrice Monitoring Extension
26th Mar 20077:01 amRNSTrading Statement
22nd Mar 20073:46 pmRNSHolding(s) in Company
19th Mar 200712:08 pmRNSHolding(s) in Company
26th Feb 20073:41 pmRNSHolding(s) in Company
2nd Feb 200712:40 pmRNSHolding(s) in Company
1st Feb 200710:33 amRNSHolding(s) in Company
30th Jan 20076:28 pmRNSDirector/PDMR Shareholding
25th Jan 20074:56 pmRNSHolding(s) in Company
24th Jan 200710:46 amRNSHolding(s) in Company
8th Jan 200710:22 amRNSBlocklisting Interim Review
18th Dec 20064:33 pmRNSTotal Voting Rights
6th Dec 200610:19 amRNSHolding(s) in Company
4th Dec 20067:01 amRNSInterim Results
8th Nov 20067:00 amRNSNotice of Results
26th Oct 20063:23 pmRNSHolding(s) in Company
24th Oct 20063:08 pmRNSHolding(s) in Company
27th Sep 20067:00 amRNSTrading Statement
7th Sep 20062:44 pmRNSHolding(s) in Company
7th Sep 20062:25 pmRNSHolding(s) in Company
7th Sep 20062:22 pmRNSHolding(s) in Company
10th Aug 20063:54 pmRNSBlocklisting Interim Review
8th Aug 200612:07 pmRNSResult of AGM
7th Aug 20065:57 pmRNSHolding(s) in Company
12th Jul 200612:23 pmRNSAnnual Information Update
10th Jul 20062:41 pmRNSAnnual Report and Accounts
10th Jul 20069:06 amRNSDisposal
27th Jun 20067:00 amRNSDirector/PDMR Shareholding
26th Jun 20066:18 pmRNSDirector/PDMR Shareholding
26th Jun 20066:12 pmRNSDirector/PDMR Shareholding
26th Jun 20066:12 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.